SCHEMBL27028537

SCHEMBL27028537

CCCn1nc(C)cc1-c1c[nH]cn1

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 3/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ GLS O94925 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27028475 0.89 ADORA2B (0.40) ADORA2BADORA2AGLSKDM4EALDH1A1
SCHEMBL27200014 0.84 HPGD (0.34) GLS
SCHEMBL27200041 0.82 GLS (0.31) GLS
SCHEMBL27200031 0.81 MAP3K14 (0.35) ADORA2BADORA2AGLSKDM4E
SCHEMBL27200017 0.81 KCNJ6 (0.34) GLS
SCHEMBL27028481 0.81 GAA (0.34) GLSALDH1A1
SCHEMBL27200033 0.80 GAA (0.37) KDM4E
SCHEMBL27200074 0.80 KDM4E (0.31) KDM4E
SCHEMBL27200051 0.80 CRHR1 (0.35) GLSALDH1A1
SCHEMBL27028523 0.76 ADORA2B (0.37) ADORA2BADORA2AGLSKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240383903-A1 Modulators of STING (Stimulator of Interferon Genes) PFIZER INC. (US) 2024-11-21 — — US disclosed
US-11964978-B2 Modulators of STING (stimulator of interferon genes) PFIZER INC. (US) 2024-04-23 — — US disclosed
EP-4308563-A1 MODULATORS OF STING (STIMULATOR OF INTERFERON GENES) Pfizer Inc. (US) 2024-01-24 — — EP disclosed
CN-117321055-A Modulators of STING (interferon gene stimulators) 辉瑞公司 2023-12-29 — — CN disclosed
US-20220306641-A1 Modulators of STING (Stimulator of Interferon Genes) PFIZER INC. (US) 2022-09-29 — — US disclosed
WO-2022195462-A1 MODULATORS OF STING (STIMULATOR OF INTERFERON GENES) PFIZER INC. (US) 2022-09-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11964978-B2 Modulators of STING (stimulator of interferon genes) STING1, IRF3, CGAS ADORA2B 1784/4885ADORA2A 1302/4885GLS 1261/4885
US-20220306641-A1 Modulators of STING (Stimulator of Interferon Genes) STING1, IRF3, CGAS ADORA2B 1784/4885ADORA2A 1302/4885GLS 1261/4885
US-20240383903-A1 Modulators of STING (Stimulator of Interferon Genes) STING1, IRF3, CGAS ADORA2B 1784/4885ADORA2A 1302/4885GLS 1261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback